This Week's First IPO: Global Blood Therapeutics Developing Drugs For Diseases Affecting Few
August 13, 2015 at 09:23 AM EDT
Global Blood Therapeutics (NASDAQ: GBT) priced its 6 million share IPO above its expected $16 to $18 range at $20 per share Tuesday ...
